You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 106.4 KDa. Observed: 130-170 KDa, reducing conditions
Human
Met22-Arg734
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.5 KDa. Observed: 60-90 KDa, reducing conditions
Human
Asp26-Ala188
C-Fc
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 32.7 KDa. Observed: 35-40 KDa, reducing conditions
Human
Met1-Gln279
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 43 KDa. Observed: 60 KDa, reducing conditions
Mouse
Asn20-Lys149
C-Fc-6His
10 μg, 1 mg, 50 μg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 72.7 KDa. Observed: 70-90 KDa, reducing conditions
Mouse
Thr33-His682
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 69.6 KDa. Observed: 90-120 KDa, reducing conditions
Human
Leu25-Ser645
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC.(QC verified)
Predicted: 15.1&16 KDa. Observed: 15-25 KDa, reducing conditions
Human
Gly24-Ala155&Arg31-Gln163
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 16.2 KDa. Observed: 16-18 KDa, reducing conditions
Human
Met113-Leu261
Tag free
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 95.7 KDa. Observed: 120-160 KDa, reducing conditions
Human
Leu25-Ser645
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 60.6 KDa. Observed: 90-120 KDa, reducing conditions
Human
Leu33-Trp320
C-Fc
10 μg, 50 μg, 500 μg, 1 mg